Based on these results, seven genes (ATP9B, GALR1, HSBP1L1, KCNG2, NFATC1, PARD6G and SALL3) could distinguish HNSCC samples from normal samples, and these were selected for further testing using the expanded cohort. This evidence concerns the gene GALR1 and head and neck squamous cell carcinoma.